You just read:

Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes

News provided by

Lexicon Pharmaceuticals, Inc.

21 Dec, 2016, 06:45 ET